Stoop, Thomas F.
Fröberg, Klara
Sparrelid, Ernesto
Del Chiaro, Marco
Ghorbani, Poya
Funding for this research was provided by:
Karolinska Institute
Article History
Received: 26 April 2022
Accepted: 9 October 2022
First Online: 8 November 2022
Declarations
:
: (1) Marco Del Chiaro has been awarded with an industry grant (Haemonetics, Inc) to conduct a multicenter study to evaluate the prognostic implications of TEG in pancreatic cancer. (2) Marco Del Chiaro is co-principal investigator of a Boston Scientific sponsored international multicenter study on the use of intraoperative pancreatoscopy of patients with IPMN.
: (1) Marco Del Chiaro has been awarded with an industry grant (Haemonetics, Inc.) to conduct a multicentre study to evaluate the prognostic implications of TEG in pancreatic cancer.(2) Marco Del Chiaro is co-principal investigator of a Boston Scientific sponsored international multicentre study on the use of intraoperative pancreatoscopy of patients with IPMN.